Immunic | VTL - Ativo Circulante





Ativo Circulante Alterar Data
Alterity Therapeutics Limited AUD 37.91M 15.92M 2025-12
BioMarin Pharmaceutical USD 4.61B 651.58M 2026-03
Cipla INR 249.18B 16.3B 2025-09
Clal Biotechnology ILS 14.69M 1.95M 2023-12
Compugen USD 148.02M 59.1M 2025-12
CSL USD 11.85B 1000K 2025-12
Enanta Pharmaceuticals USD 198.68M 5.65M 2025-12
Grifols EUR 5.96B 316.31M 2025-12
Immunic USD 22.87M 16.4M 2025-12
Insmed USD 1.79B 137.6M 2025-12
Omeros USD 69.65M 26.53M 2025-06
OraSure Technologies USD 261.91M 21.1M 2025-12
Quidel USD 1.38B 70.3M 2026-03
Ultragenyx Pharmaceutical USD 657M 294M 2026-03
United Therapeutics USD 2.87B 830.5M 2026-03
Xoma USD 110.71M 5.78M 2025-09